Andere Suchmöglichkeiten:
kinases inhibition » bias inhibition
oxidase inhibition » bias inhibition
kanal inhibition » kanal inhibierung, bias inhibition, ncx inhibition
inhibition after » institution after, infection after
pain inhibitor » pain inhibition, pump inhibitor, 2a inhibitor
cva inhibition » c5 inhibition, bias inhibition, _ inhibition
1.9 inhibition » 3.5 inhibition, 6.6 inhibition, 1.6.1 inhibition
kinases inhibition » bias inhibition
oxidase inhibition » bias inhibition
kanal inhibition » kanal inhibierung, bias inhibition, ncx inhibition
inhibition after » institution after, infection after
pain inhibitor » pain inhibition, pump inhibitor, 2a inhibitor
cva inhibition » c5 inhibition, bias inhibition, _ inhibition
1.9 inhibition » 3.5 inhibition, 6.6 inhibition, 1.6.1 inhibition
1
2
3
Falke, Isabel, Troschel, Fabian Martin, Palenta, Heike, Löblein, Maria T., Brüggemann, Kathrin, Borrmann, Katrin, Eich, Hans-Theodor, Götte, Martin, Greve, Burkhard
2022
Schlagwörter:
“...Musashi-1 Cancer stem cell Endometrial cancer Proliferation Radioresistance...”2022
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Krekeler, Carolin, Wethmar, Klaus, Mikesch, Jan-Henrik, Kerkhoff, Andrea, Menck, Kerstin, Lenz, Georg, Schildhaus, Hans-Ulrich, Wessolly, Michael, Hoffmann, Matthias W., Pascher, Andreas, Asmus, Inga, Wardelmann, Eva, Bleckmann, Annalen
2023
Schlagwörter:
“...immune checkpoint inhibition nivolumab ipilimumab microsatellite instability metastatic colorectal...”2023
18
19
Ventura, David, Schindler, Philipp, Masthoff, Max, Görlich, Dennis, Dittmann, Matthias, Heindel, Walter, Schäfers, Michael, Lenz, Georg, Wardelmann, Eva, Mohr, Michael, Kies, Peter, Bleckmann, Annalen, Roll, Wolfgang, Evers, Georg Heribert
2023
Schlagwörter:
“...radiomics FDG-PET-CT NSCLC PD-L1 PD-1 immune checkpoint inhibition pembrolizumab artificial...”2023
20
Vollenberg, Richard, Lorentzen, Eva Ulla, Kühn, Joachim, Nowacki, Tobias Max, Meier, Jörn Arne, Trebicka, Jonel, Tepasse, Phil-Robin
2023
Schlagwörter:
“...SARS-CoV-2 COVID-19 vaccination IBD patients seroconversion humoral immune response...”2023